Leonard Paolillo
2021
In 2021, Leonard Paolillo earned a total compensation of $2.3M as Chief Commercial Officer at IMPEL PHARMACEUTICALS.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Non-Equity Incentive Plan | $156,456 |
| Option Awards | $1,297,082 |
| Salary | $305,240 |
| Stock Awards | $466,500 |
| Total | $2,260,278 |
Paolillo received $1.3M in option awards, accounting for 57% of the total pay in 2021.
Paolillo also received $35K in bonus, $156.5K in non-equity incentive plan, $305.2K in salary and $466.5K in stock awards.
Rankings
In 2021, Leonard Paolillo's compensation ranked 5,561st out of 12,405 executives tracked by ExecPay. In other words, Paolillo earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,561 out of 12,405 | 55th |
Division Manufacturing | 2,351 out of 5,494 | 57th |
Major group Chemicals And Allied Products | 1,021 out of 2,369 | 57th |
Industry group Drugs | 910 out of 2,090 | 57th |
Industry Pharmaceutical Preparations | 655 out of 1,537 | 57th |
Source: SEC filing on April 26, 2022.
Paolillo's colleagues
We found two more compensation records of executives who worked with Leonard Paolillo at IMPEL PHARMACEUTICALS in 2021.